SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-17-070186
Filing Date
2017-11-22
Accepted
2017-11-22 16:06:45
Documents
1
Group Members
HEIGHTS CAPITAL MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-27397_1sc13g.htm SC 13G 102235
  Complete submission text file 0001104659-17-070186.txt   104011
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Subject) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86352 | Film No.: 171219954
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

IRS No.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G